)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Looking back, moving on: Doctors, nurses, ambulance drivers say Covid-19 has left them life-altering lessons
Apart from the engines, the factory will also manufacture low to zero-emission technology products
sickle cell disease is a genetic blood disorder that causes severe pain and complications. It is particularly prevalent among tribal populations in India
This new facility follows the success of the company's four existing RVSFs located in Jaipur, Bhubaneswar, Surat, and Chandigarh
Collaboration with Cosmo enables rights for cream in several countries, says company
Clinisys holds a leadership position in the clinical laboratory information systems market, with a 19 per cent share of the market
Doctors in India view this move as temporary, citing the high number of doctors produced in the country each year
Credit rating agency ICRA expects the initial cost of an electric two-wheeler (e-2W) to increase by 10 per cent due to the reduced subsidy
Short duration, stricter compliance pushes EV makers to consider selling vehicles sans subsidy
The Series B funds raised from Naik and other investors would be used to set up a state-of-the-art integrated manufacturing facility for neurovascular devices in Karnataka
Recent research suggests that insulin eye drops can be effective in repairing corneal tissue and treating ocular surface conditions
Collaboration aligns with Sanofi's growth strategy in India, named 'India for India', aims to accelerate growth across its pharmaceuticals, specialty care, consumer healthcare, and vaccines business
Drug manufacturers with annual turnovers below Rs 500 crore will get the financial assistance in upgrading their facilities to meet global standards
The acquisition strengthens Nirma's presence in the pharmaceuticals and life sciences sector
Mankind Pharma, a pharmaceutical company in India, boasts a vast distribution network with over 16,000 field personnel and 13,000 stockists
Doctors used Zidebactam/Cefepime to treat a highly drug-resistant skull bone infection and pneumonia in a renal transplant patient
Our dominance in the consumer group is unparalleled, especially in the auto portal segment, said Aneesha Menon
Data from healthcare platforms reveals surge in cardiac consultations, preventive checkups
Under the agreement, Biocon Biologics will launch Yesafili no later than July 1, 2025. Health Canada had granted tentative approval for Yesafili in March 2023
Cadiflu Tetra is developed employing Nano-sized particles, the Vaccine mimics the external structure of the virus without containing intact genetic material